Neurocrine Biosciences Inc (FRA:NB3)
€ 141.2 +1.3 (+0.93%) Market Cap: 14.67 Bil Enterprise Value: 13.87 Bil PE Ratio: 25.59 PB Ratio: 4.90 GF Score: 95/100

Neurocrine Biosciences Inc (FRA:NB3) Transcripts

  • 1